Neksium

📦 Elke bestelling is gedekt door onze Reshipment Assurance Policy — als uw pakket niet binnen 20 werkdagen arriveert, sturen wij het opnieuw.

Waarom bestellen bij MedsBase

Onze generieke medicijnen zijn afkomstig van WHO-GMP gecertificeerde fabrikanten en worden wereldwijd verzonden in discrete, eenvoudige verpakkingen — geen medicijnnaam op de buitenkant van het pakket. Betalingen met kaart worden verwerkt via een gereguleerde processor (betalingsoverzichten vermelden een gereguleerde kaartbetalingprocessor — nooit “MedsBase” of een medicijnnaam). Crypto en SEPA bankoverschrijvingen worden ook geaccepteerd. Elke bestelling wordt ondersteund door ons Reshipment Assurance Policy.

What Neksium (Esomeprazole) Is

Neksium is the AstraZeneca India brand of esomeprazole, a benzimidazole proton-pump inhibitor (PPI). Each tablets contains 20 mg / 40 mg of esomeprazole. PPIs are the most potent class of acid-suppressing medicines available and are first-line therapy for moderate-to-severe acid-related disease.

How Neksium Works (Mechanism)

Proton-pump inhibitors are prodrugs. After absorption from the small intestine, the drug enters the bloodstream and is concentrated in the acidic secretory canaliculi of the stomach’s parietal cells. There the acid environment protonates the molecule into its active sulphenamide form, which then forms a covalent disulphide bond with cysteine residues on the H⁺/K⁺-ATPase pump — the final step in acid secretion. Because the bond is irreversible, acid output cannot resume until the parietal cell synthesises new pumps. This pharmacodynamic effect lasts 24–72 hours even though the drug’s plasma half-life is only ~1–2 hours (longer for ilaprazole). Maximal acid suppression takes 3–5 days of regular dosing.

How esomeprazole differs from the other PPIs: Esomeprazole is the pure S-enantiomer of omeprazole. Because the S-isomer is cleared more slowly than the R-isomer, esomeprazole produces ~30% higher plasma exposure (AUC) at the same milligram dose and shows less inter-individual variability than omeprazole. In head-to-head erosive-oesophagitis healing studies (esomeprazole 40 mg vs. omeprazole 20 mg) esomeprazole gave faster and more complete healing — which is why it is often the preferred PPI for severe erosive disease. Esomeprazole still inhibits CYP2C19 and therefore carries the same clopidogrel interaction concern as omeprazole; switch to pantoprazole or rabeprazole if you take clopidogrel.

Indications — What Neksium Treats

1. Gastro-oesophageal reflux disease (GERD)

The most common indication. Neksium is used for symptomatic GERD with or without endoscopic oesophagitis. Once-daily dosing is sufficient for the majority of patients; a small subset with night-time symptoms benefit from twice-daily dosing or a switch to a longer-half-life PPI. Lifestyle measures — weight loss, head-of-bed elevation, avoiding meals within 3 hours of bedtime, reducing alcohol, coffee and tobacco, and avoiding known triggers — should accompany drug therapy.

2. Erosive oesophagitis

Endoscopically confirmed inflammation or ulceration of the lower oesophagus. PPIs heal ~85–95% of erosive oesophagitis at 8 weeks of standard-dose therapy. Severe (Los Angeles grade C/D) disease may need 8–12 weeks of double-dose PPI before transitioning to a maintenance dose. Continued maintenance therapy is recommended because recurrence is the rule rather than the exception.

3. Peptic ulcer disease — gastric and duodenal ulcers

PPIs heal duodenal ulcers in 4 weeks (~95% healing rate) and gastric ulcers in 8 weeks. Helicobacter pylori infection (the cause of the majority of non-NSAID peptic ulcers) must be tested for and eradicated to prevent recurrence.

4. Helicobacter pylori eradication

Neksium is part of standard H. pylori eradication regimens. Common regimens include:

• Bismuth quadruple therapy (preferred where clarithromycin resistance is high): PPI twice daily + bismuth subcitrate 120 mg four times daily + tetracycline 500 mg four times daily + metronidazole 500 mg three times daily, for 14 days.
• Clarithromycin triple therapy: PPI twice daily + amoxicillin 1 g twice daily + clarithromycin 500 mg twice daily, for 14 days. (Avoid where local clarithromycin resistance > 15%.)
• Concomitant therapy: PPI + amoxicillin + clarithromycin + metronidazole, all twice daily, for 10–14 days.

Confirm eradication with urea breath test or stool antigen test 4 weeks after completing therapy and at least 2 weeks off PPI — PPIs cause false-negative results.

5. NSAID-associated ulcer prevention

For patients who must continue chronic NSAID therapy and have a higher ulcer risk (age > 65, prior ulcer, concurrent corticosteroid or anticoagulant, high NSAID dose), once-daily PPI co-prescription substantially reduces gastric and duodenal ulcer incidence.

6. Zollinger-Ellison syndrome

This rare gastrin-secreting tumour produces extreme acid hypersecretion. PPIs at much higher than usual doses (often 80–120 mg pantoprazole/day or equivalent, divided) are the cornerstone of medical therapy alongside tumour localisation and surgical/oncological management.

7. Functional dyspepsia and non-erosive reflux disease

A trial of 4–8 weeks of PPI is reasonable for symptomatic functional dyspepsia or non-erosive reflux disease, with reassessment of need afterwards. Many patients in this group can step down to on-demand or H₂-antagonist therapy.

Dosering

Take Neksium 30–60 minutes before the first meal of the day. The drug needs to reach the parietal cell while the meal is stimulating proton-pump activity — PPIs only inactivate active pumps. Taking it after the meal, or with the meal, gives a smaller pharmacodynamic effect. Swallow tablets whole; do not crush or chew (the enteric coating is critical).

Long-Term Safety — What to Know Before Months of Use

Bijwerkingen

Common (1–10%):

• Hoofdpijn
• Diarrhoea or constipation
• Abdominal pain or flatulence
• Misselijkheid
• Mild rash
• Duizeligheid

Zeldzaam maar belangrijk:

• Acute interstitial nephritis (rare; idiosyncratic)
• Severe hypomagnesaemia (long-term use)
• Vitamin B₁₂ deficiency (long-term use)
• Cutaneous and systemic lupus erythematosus (rare; reversible on stopping)
• Fundic gland polyps (benign; long-term use)
• Severe hypersensitivity / Stevens-Johnson syndrome (very rare)
• Bone fracture (osteoporotic patients on long-term high-dose)

Geneesmiddelinteracties

Esomeprazole is metabolised partly by CYP2C19. The interactions table below covers the main classes; tell your prescriber every medicine, supplement and herbal preparation you take before starting.

How to Stop Neksium

Long-term PPI users often experience rebound acid hypersecretion when the drug is stopped abruptly — transient symptoms for 2–4 weeks that can be misinterpreted as “needing the PPI for life”. The recommended approach is to step down rather than stop:

1. If on twice-daily dosing, drop to once-daily for 2 weeks.
2. Halve the dose for another 2 weeks (e.g. 20 mg on alternate days, or step to a lower-strength tablet).
3. Switch to op aanvraag dosing — take a PPI only when symptoms occur.
4. Bridge with a histamine-H₂ antagonist (famotidine 20 mg as needed) for breakthrough symptoms during the step-down.
5. Antacids (e.g. Acigene) can be used for occasional break-through episodes during weaning.

Lifestyle measures (head-of-bed elevation, late-meal avoidance, weight loss, alcohol/coffee reduction) reduce reliance on acid-suppressive medication.

Contra-indicaties en voorzorgsmaatregelen

• Known hypersensitivity to esomeprazole or any benzimidazole PPI
• Concurrent use of rilpivirine (HIV) — absolute contraindication
• Severe hepatic impairment — reduce dose
• Patients on clopidogrel post-stent (consider switch to pantoprazole or rabeprazole if on omeprazole/esomeprazole)
• Long-standing alarm symptoms (weight loss, dysphagia, GI bleeding, anaemia, age > 55 with new symptoms) — require investigation, not empirical PPI therapy

Pregnancy, Breastfeeding, and Children

Zwangerschap: Acid-related symptoms are common in pregnancy. Antacids and sucralfate are first line. If a PPI is needed, omeprazole has the largest pregnancy safety database; pantoprazole, lansoprazole and esomeprazole all have reasonable safety data. Avoid in first trimester unless symptoms are severe or refractory.

Borstvoeding: Small amounts pass into breast milk; the consensus is that PPIs are compatible with breastfeeding.

Kinderen: Several PPIs (omeprazole, lansoprazole, esomeprazole) are approved for paediatric GERD with weight-based dosing. Pantoprazole has more limited paediatric data. Discuss with a paediatric gastroenterologist before starting.

Opslag

Store at 15–30 °C in the original blister, protected from moisture and direct sunlight. Keep out of the reach of children. Do not transfer tablets to weekly pillboxes for prolonged periods because moisture exposure degrades the enteric coating.

Veelgestelde vragen

When should I take Neksium — before or after food?

Take Neksium 30–60 minutes before the first meal of the day. Proton-pump inhibitors only inactivate active proton pumps. Eating stimulates pump activity, and the drug must be in the bloodstream when this happens. Taking it after the meal, with the meal, or at bedtime gives a substantially smaller acid-suppressing effect.

How long does Neksium take to work?

Some symptom improvement is often noticed within 24–72 hours, but the drug’s full pharmacodynamic effect takes 3–5 days of consecutive daily dosing because new proton pumps must be turned over before suppression reaches steady state. If you have not seen meaningful symptom relief after 2 weeks of correctly timed daily dosing at the standard 20 mg dose, talk to your prescriber — you may need a higher dose, a different PPI, additional H₂-antagonist coverage, or investigation for an alternative diagnosis.

Can I take Neksium long-term?

Many patients with chronic GERD or Barrett’s oesophagus do take a PPI long-term, and the benefit usually outweighs the risks at the lowest effective dose. Long-term concerns — vitamin B₁₂ and magnesium deficiency, fracture, C. difficile infection, fundic gland polyps, and very rarely chronic kidney disease — are why the principle is lowest effective dose for the shortest necessary duration, with annual review of need. If you are on a PPI for more than 2 years, ask about checking serum B₁₂ and magnesium.

What happens if I stop Neksium suddenly?

Stopping a long-term PPI abruptly can cause rebound acid hypersecretion — transient worsening of heartburn for 2–4 weeks even in people who never had reflux symptoms before starting. This is a pharmacological phenomenon, not return of the original disease. Step down the dose over 2–4 weeks; bridge with famotidine 20 mg as needed, or an antacid for break-through episodes.

Can I drink alcohol while taking Neksium?

There is no direct dangerous interaction between alcohol and PPIs, but alcohol is a major reflux trigger — it relaxes the lower oesophageal sphincter and stimulates acid secretion. If reflux is the reason you are taking Neksium, cutting back on alcohol substantially improves the response.

How does Esomeprazole compare with the other PPIs?

Esomeprazole is the pure S-isomer of omeprazole and gives ~30% higher plasma exposure (AUC) at the same milligram dose, which translates to faster and more complete healing of severe erosive oesophagitis. It still inhibits CYP2C19 to a similar degree as omeprazole, so the clopidogrel concern is the same. If you have severe erosive disease, esomeprazole is often a better choice than generic omeprazole; if you take clopidogrel, switch to pantoprazole or rabeprazole.

Can I take an antacid alongside Neksium?

Yes. Antacids (such as Acigene) work by neutralising acid that has already been secreted, while PPIs reduce future acid secretion. They are complementary — an antacid is useful for fast-onset symptom relief during the first few days of PPI therapy or for occasional break-through episodes once on PPI maintenance. Take the antacid at least 1–2 hours away from the PPI and from any other medication that could be affected by altered absorption.

Will Neksium interact with my heart medication?

The most important PPI-cardiology interaction is with clopidogrel. Inhibition of CYP2C19 reduces conversion of clopidogrel to its active metabolite. Switch to pantoprazole or rabeprazole if antiplatelet protection is critical (post-stent). PPIs have only minor effects on warfarin INR — recheck INR 5–7 days after starting or stopping. PPIs have no clinically significant interaction with statins, beta-blockers, or ACE inhibitors at standard doses.

Is Neksium safe in pregnancy?

Antacids and sucralfate are preferred first-line in pregnancy. If a PPI is needed, omeprazole has the largest safety database, but pantoprazole, lansoprazole and esomeprazole are all considered to have a reasonable safety profile in pregnancy. Avoid in the first trimester if symptoms can be controlled by lifestyle and antacid measures. Talk to your obstetrician.

Should I take Neksium if I have an H. pylori infection?

Yes — PPIs are an essential part of every H. pylori eradication regimen. The PPI raises gastric pH, which makes the antibiotics (amoxicillin, clarithromycin, tetracycline, metronidazole) more effective and reduces the bacterium’s metabolic activity. After completing 10–14 days of combination therapy, you should usually continue the PPI alone for another 4–8 weeks if there is concurrent ulcer disease. Confirm eradication with urea breath test or stool antigen test 4 weeks after finishing antibiotics — and at least 2 weeks off PPI, which can otherwise cause false-negative results.

Gerelateerde alternatieven

Andere producten in Algemene gezondheid die klanten ook bekijken:

• Olopat Oogdruppels
• Metopar
• Toba Dm Oogdruppels
• Latoprost Oogdruppels
• Odoxil

More options in Acid Reflux Treatment

Gerangschikt op recente bestelvolumes van MedsBase — wat andere klanten in deze categorie kiezen.

Famocid

US$1.00 – US$6.00Faixa de preço: US$1.00 até US$6.00

Omez

US$4.35 – US$33.10Faixa de preço: US$4.35 até US$33.10

Nexpro

US$5.30 – US$29.70Faixa de preço: US$5.30 até US$29.70